Safety and Efficacy of SHPL-49 Injection in Participants With Acute Ischemic Stroke

Conditions: Acute Ischemic Stroke Interventions: Drug: 3 ampoules of SHPL-49 Injection; Drug: 6 ampoules of SHPL-49 Injection; Drug: 0.9% Sodium Chloride Injection Sponsors: Shanghai Hutchison Pharmaceuticals Limited; Beijing Tiantan Hospital Recruiting

https://clinicaltrials.gov/study/NCT06202378

Source: ClinicalTrials.gov - January 11, 2024 Category: Research Source Type: clinical trials